Clinical Trial Update: A Study of Ranolazine in ALS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ranolazine in amyotrophic lateral sclerosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Swathy Chandrashekhar, MBBS | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: RECRUITING